Key indicators: single-crystal X-ray study; T = 294 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.042; wR factor = 0.119; data-to-parameter ratio = 13.4.
Cocrystallization of 1-hydroxyethyl-2-methyl-5-nitroimidazole (metronidazole) and 5-sulfosalicylic acid (5-H 2 SSA) from methanol solution yields the title salt, C 6 H 10 N 3 O 3 + ÁC 7 H 5 O 6 S À . In the crystal structure, the ions are linked by a combination of intermolecular O-HÁ Á ÁO, N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds, forming a three-dimensional framework. The hydroxyl group of the cation is disordered over two sites in a 0.860 (4):0.140 (4) ratio. 
Related literature

Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Castelli et al., 2000; Cohen-Jonathan et al., 2001; Hodgkiss et al., 1998) . However, the low solubility in water makes its absorption in human body much less than expected. Recently, many efforts have been devoted to developing some new substitutes for the medicine, i.e. i) metal-organic coordination compounds (Kennedy et al., 2006; Galván-Tejada et al., 2002; Athar et al., 2005; Bharti et al., 2002; Wu et al., 2003) , ii) organic substitute derivatives (Crozet et al., 2002 , Skupin et al., 1997 and iii) pharmaceutical co-crystals. In this paper, we report the 1:1 molecular adduct formed by metronidazole 5-sulfosalicylic acid (5-H 2 SSA), (I).
In (I), the H atom is transferred from the sulfonic acid group to the imidazole N atom (Fig.1 ) forming an 1:1 organic adduct, which is similar to the analogous organic adducts reported (Meng et al., 2007) . The hydroxyl O atom is disordered at two sites with occupancy being 0.86 (1)/0.14 (1) for the major and minor components, respectively.
In the crystal packing, the component ions are linked by a combination of O-H···O, N-H···O and C-H···O hydrogen bonds (Table 1) , forming a three-dimensional network (Fig.2 ). There are no other interactions (e.g. C-H···π and π-π) observed in the crystal structure by using PLATON (Spek, 2003) .
All the reagents and solvents were used as obtained without further purification. Equivalent molar amount of metronidazole and 5-sulfosalicylic acid dihydrate were dissolved in methanol (10 ml). The mixture was stirred for ten minutes at 300 K and then filtered. Block colorless crystals of (I) suitable for single-crystal X-ray diffraction analysis were grown by slow evaporation of the solution at the bottom of the vessel in two days. 
